Pharma Market Access Insights - from Petauri Evidence

podcast

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of ...

Business 74 recordings 2020 → today Monthly updated Apr 21
Search in Pharma Market Access Insights - from Petauri Evidence →

All episodes

41–60 of 74
Integrated Care Systems go live in the NHS - reflections after 3 weeks contributed by Lukas · Aug 9, 2022
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role contributed by Lukas · Aug 1, 2022
Transforming systems and care pathways for an integrated NHS contributed by Lukas · Jun 21, 2022
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers contributed by Lukas · May 4, 2022
Population to Person: How will the NHS translate population health management into impactful, person-centred service change? contributed by Lukas · Mar 15, 2022
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? contributed by Lukas · Feb 11, 2022
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion contributed by Lukas · Jan 17, 2022
Optimising the NHS – How will medicines be valued in integrated systems? contributed by Lukas · Dec 21, 2021
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe contributed by Lukas · Nov 29, 2021
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales) contributed by Lukas · Oct 1, 2021
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help contributed by Lukas · Sep 10, 2021
The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving contributed by Lukas · Jul 6, 2021
Population to person - How will the voice of the individual drive health and care development? contributed by Lukas · Jun 2, 2021
Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE contributed by Lukas · May 17, 2021
Health Economic Modelling for MedTech Innovation - What, Why and How contributed by Lukas · Apr 14, 2021
Pharmacy, Medicines, and Specialised Commissioning in the new NHS contributed by Lukas · Apr 12, 2021
The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester contributed by Lukas · Mar 11, 2021
Heads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust) contributed by Lukas · Feb 5, 2021
Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus contributed by Lukas · Jan 13, 2021
Is prevention better than the cure? How can the NHS and public health work closer to improve population health? contributed by Lukas · Nov 27, 2020
page 3 of 4 «« ← Prev Next → »»

Charts

module · podcast

🇮🇪 #59 · 🇮🇳 #75 · 🇪🇸 #84 · 🇨🇭 #94 · 🇦🇷 #142 · 🇬🇧 #186 · +12 more

charted in 19 countriesFull rankings →

Activity

module · podcast

0 episodes · last 30 days

Mon 2Tue 1Wed 1

Episodes per week over the last six months.

About

module · podcast

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

Petauri Evidence mtechaccess.co.uk RSS Apple